These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 1336544

  • 1. Expression of the p53 protein in a spectrum of astrocytic tumours.
    Ellison DW, Gatter KC, Steart PV, Lane DP, Weller RO.
    J Pathol; 1992 Dec; 168(4):383-6. PubMed ID: 1336544
    [Abstract] [Full Text] [Related]

  • 2. Immunocytochemical detection of p53 in human gliomas.
    Bruner JM, Saya H, Moser RP.
    Mod Pathol; 1991 Sep; 4(5):671-4. PubMed ID: 1758878
    [Abstract] [Full Text] [Related]

  • 3. Loss of heterozygosity of a locus on 17p13.3, independent of p53, is associated with higher grades of astrocytic tumours.
    Chattopadhyay P, Rathore A, Mathur M, Sarkar C, Mahapatra AK, Sinha S.
    Oncogene; 1997 Aug 14; 15(7):871-4. PubMed ID: 9266974
    [Abstract] [Full Text] [Related]

  • 4. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 14; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 5. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar 14; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical detection of p53 protein expression in various childhood astrocytoma subtypes: significance in tumor progression.
    Bodey B, Gröger AM, Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1997 Mar 14; 17(2A):1187-94. PubMed ID: 9137469
    [Abstract] [Full Text] [Related]

  • 7. Clonal expansion of p53 mutant cells is associated with brain tumour progression.
    Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B.
    Nature; 1992 Feb 27; 355(6363):846-7. PubMed ID: 1311419
    [Abstract] [Full Text] [Related]

  • 8. Genetic alterations associated with glioma progression.
    Kleihues P, Lübbe J, Watanabe K, von Ammon K, Ohgaki H.
    Verh Dtsch Ges Pathol; 1994 Feb 27; 78():43-7. PubMed ID: 7534015
    [Abstract] [Full Text] [Related]

  • 9. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 10. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr 01; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 11. Role of gemistocytes in astrocytoma progression.
    Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1997 Feb 01; 76(2):277-84. PubMed ID: 9042164
    [Abstract] [Full Text] [Related]

  • 12. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A, Ralte AM, Sharma MC, Singh VP, Mahapatra AK, Mehta VS, Sarkar C.
    Neurol India; 2004 Jun 01; 52(2):228-32. PubMed ID: 15269478
    [Abstract] [Full Text] [Related]

  • 13. Chromosome 17 allelic loss in astrocytic tumors and its clinico-pathologic implications.
    Muhammad AK, Yoshimine T, Maruno M, Tokiyoshi K, Takemoto O, Ninomiya H, Hayakawa T.
    Clin Neuropathol; 1997 Jun 01; 16(4):220-6. PubMed ID: 9266149
    [Abstract] [Full Text] [Related]

  • 14. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.
    Reilly KM, Loisel DA, Bronson RT, McLaughlin ME, Jacks T.
    Nat Genet; 2000 Sep 01; 26(1):109-13. PubMed ID: 10973261
    [Abstract] [Full Text] [Related]

  • 15. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S.
    Brain Tumor Pathol; 2010 Oct 01; 27(2):95-101. PubMed ID: 21046311
    [Abstract] [Full Text] [Related]

  • 16. Expression of Fas/APO-1 during the progression of astrocytomas.
    Tachibana O, Nakazawa H, Lampe J, Watanabe K, Kleihues P, Ohgaki H.
    Cancer Res; 1995 Dec 01; 55(23):5528-30. PubMed ID: 7585627
    [Abstract] [Full Text] [Related]

  • 17. Prognostic relevance of TP53 mutations, p53 protein, Ki-67 index and conventional histological grading in oligodendrogliomas.
    Hagel C, Krog B, Laas R, Stavrou DK.
    J Exp Clin Cancer Res; 1999 Sep 01; 18(3):305-9. PubMed ID: 10606174
    [Abstract] [Full Text] [Related]

  • 18. Molecular pathogenesis of pediatric astrocytic tumors.
    Nakamura M, Shimada K, Ishida E, Higuchi T, Nakase H, Sakaki T, Konishi N.
    Neuro Oncol; 2007 Apr 01; 9(2):113-23. PubMed ID: 17327574
    [Abstract] [Full Text] [Related]

  • 19. [p53: an important or most overvalued tumor gene?].
    Schlegel U.
    Laryngorhinootologie; 1994 Dec 01; 73(12):651-3. PubMed ID: 7840829
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis and p53 expression in human gliomas.
    Sipos L, Szegedi Z, Fedorcsák I, Afra D, Szende B.
    Pathol Oncol Res; 1998 Dec 01; 4(4):267-70. PubMed ID: 9887356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.